Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,083,377
+$5,263,262 QoQ
Shares Held
630,529
+101.0% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. NTLA ranks #48 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in NTLA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,083,377 | 630,529 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,820,115 | 313,695 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,633,693 | 210,405 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,280,743 | 136,540 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $646,118 | 90,875 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $416,925 | 35,757 | Shares | Other | 2025-02-14 | |
| 2022-09-30 | $282,486 | 5,048 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $428,469 | 8,278 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,888,329 | 25,985 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,812,368 | 40,700 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,369,039 | 47,477 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,760,110 | 35,576 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,544,404 | 31,704 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,103,776 | 20,290 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $511,790 | 25,744 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $432,486 | 20,575 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $538,401 | 44,023 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||